BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Norgine Enrolls First Patient In The Phase 3 NOCT Study To Evaluate Bowel Cleansing Efficacy Of NER1006, A Novel, Low Volume Bowel Preparation, Vs. Trisulfate

  October 3, 2014

   · 

  5 min read
• Sunshine Biopharma, Inc.'s Wholly Owned Canadian Subsidiary Completes The SOP’s Required By Health Canada To Secure Drug Establishment License

  October 3, 2014

   · 

  2 min read
• Genetown

  Corbus Pharmaceuticals, Inc. To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum In San Francisco On Wednesday, October 8, 2014

  October 3, 2014

   · 

  3 min read
• Business

  Invacare Corporation To Host Conference Call To Discuss Third Quarter 2014 Financial Results

  October 3, 2014

   · 

  1 min read
• Pharm Country

  Coverage Initiation Report Focuses On Pluristem Therapeutics

  October 3, 2014

   · 

  1 min read
• Pharm Country

  Coverage Initiation Report Focuses On CEL-SCI

  October 3, 2014

   · 

  1 min read
• Pharm Country

  MYOS To Present Positive Clinical Data At 55th Annual Conference Of The American College Of Nutrition

  October 3, 2014

   · 

  4 min read
• Deals

  Titan Pharmaceuticals Announces Pricing Of Public Offering

  October 3, 2014

   · 

  4 min read
• Business

  Sigma-Aldrich Corporation Agrees To Acquire Cell Marque To Strengthen Immunohistochemistry Business

  October 3, 2014

   · 

  4 min read
• Deals

  Immutep S.A. Picks Up Prima Biomed For $28 Million

  October 3, 2014

   · 

  7 min read